Cannabinoid Research Initiative of Saskatchewan (CRIS), University of Saskatchewan, Saskatoon, Saskatchewan
Division of Pediatric Neurology, Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan
Division of Pediatric Neurology, Department of Pediatrics, University of Alberta, Edmonton, Alberta
Saskatchewan Health Authority, Saskatoon Area and Department of Psychology, University of Saskatchewan, Saskatoon, Saskatchewan
College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan
Department of Pathology and Laboratory Medicine, Saskatchewan Health Authority, Saskatoon, Saskatchewan
Cell Signalling Laboratory, Departments of Psychiatry and Physiology, University of Saskatchewan, Saskatoon, Saskatchewan
Department of Pharmaceutical Services, Saskatchewan Health Authority, Saskatoon, Saskatchewan
Department of Pediatrics, University of Saskatchewan, Saskatoon, Saskatchewan
Institute for Drug Research, School of Pharmacy, Faculty of Medicine, Hebrew University, Ein Kerem Campus, Jerusalem
Correspondence: Richard James Huntsman, Division of Pediatric Neurology, Department of Pediatrics, University of Saskatchewan, Royal University Hospital, 103 Hospital Drive, Saskatoon, Saskatchewan S7N-0W8. Telephone (306)-844-1236, fax (306)-844-1535, e-mail [email protected]
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
